ANGIOTECH PHARMACEUTICALS INC Share-based Payment Arrangement, Expense
ANGIOTECH PHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $2.80 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-12-31 was $800.00K.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-09-30 was $700.00K, a 81.08% decline year-over-year.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-06-30 was $700.00K.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-03-31 was $600.00K.
- ANGIOTECH PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2012 was $2.80M.
| Period end | Share-based Payment Arrangement, Expense 2 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 5 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 8 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.50M derived: sum of 2 quarters · filed 2013-03-28 | $2.20M derived: sum of 3 quarters · filed 2013-03-28 | $2.80M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $700.00K 10-Q · filed 2012-11-14 | $1.40M derived: sum of 2 quarters · filed 2012-11-14 | $2.00M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $700.00K 10-Q/A · filed 2012-09-13 | $1.30M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $600.00K derived: 10-K 12 month − 3 quarters · filed 2013-03-28 | ||||||
| 2011-12-31 | $9.80M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | $3.70M 10-Q · filed 2012-11-14 | $3.70M 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-13 |